Anti-Mesothelin CAR-T Cells

Catalog #
78729
$1,600 *
Size: 1 vial
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Anti-mesothelin CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-Mesothelin CAR Lentivirus (Mesothelin ScFv-CD8-4-1BB-CD3ζ; BPS Bioscience #78703). These ready-to use CAR-T cells express an anti-Mesothelin CAR consisting of the scFv (Single chain fragment variable) of anti-Mesothelin (clone P4) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1).

These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Figure 1: Construct diagram showing components of the anti-Mesothelin CAR expressed in anti-Mesothelin CAR-T cells.

Synonyms
CAK1 antigen, Pre-pro-megakaryocyte-potentiating factor, Megakaryocyte-potentiating factor (MPF), MSLN, MPF, SMRP
Product Info
Storage and Usage
Citations
Supplied As
Each vial contains 2 x 106 cells in 1 ml of CryoStor® CS10 (Stemcell Technologies)
Materials Required But Not Supplied
Name Ordering Information
Human Interleukin-2       BPS Bioscience #90184
Human CD3/CD28/CD2 T Cell Activator Stemcell Technologies #10970
Biotinylated Human Mesothelin BPS Bioscience #100291
PE-Streptavidin Biolegend #405203
Mesothelin- CHO Recombinant Cell Line BPS Bioscience #78132
IFN-g (Human) Colorimetric ELISA Detection Kit BPS Bioscience #79777

 

Recommended anti-Mesothelin CAR-T Cell Medium: TCellM™ (BPS Bioscience #78753) supplemented with 10 ng/ml Interleukin-2 (BPS Bioscience #90184).

UniProt #
Q13421
Mycoplasma Testing

The cells have been screened to confirm the absence of Mycoplasma species.

Background

Mesothelin (MSLN) is a glycophosphatidylinositol (GPI) linked cell-surface protein that is produced as a ~70 kDa precursor protein and cleaved by Furin protease to generate the ~40 kDa mature form. MSLN is frequently overexpressed in mesothelioma, ovarian, pancreatic, and non-small cell lung cancers, while its expression in normal tissues is restricted to the mesothelial lining. MSLN is a tumor-associated antigen and has been an attractive target for targeted immunotherapy approaches, including drug-conjugated antibodies and chimeric antigen receptor T cells (CAR-T Cells).